HEPATITIS-C VIRUS-INFECTION IN ICELAND - A RECENTLY INTRODUCED BLOOD-BORNE DISEASE

被引：11

作者：

LOVE, A

STANZEIT, B

机构：

[1] Department of Medical Virology, University of Iceland, Ármúli la, P.O. Box 8733

来源：

EPIDEMIOLOGY AND INFECTION | 1994年 / 113卷 / 03期

关键词：

D O I：

10.1017/S0950268800068540

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

This study demonstrates a very high prevalence of antibodies to hepatitis C virus among Icelandic intravenous (i.v.) drug users. Of 152 identified i.v. drug users 95 (63%) were shown to have antibodies to the hepatitis C virus. In contrast the seroprevalence in the general Icelandic population is low, (0.2%). Almost all cases of hepatitis C virus infection in Iceland are due to i.v. drug use or to use of infected blood or blood products. Sporadic cases with unexplained modes of transmission, a significant portion of hepatitis C infections elsewhere, are virtually non-existent in Iceland. The results of this study are consistent with the hypothesis that the sporadic community-acquired cases could be caused by blood transfer due to bites from insect vectors such as mosquitoes which are not found in Iceland.

引用

页码：529 / 536

页数：8

共 29 条

[21]

ROGGENDORF M, 1989, LANCET, V2, P324

[22]

SIRCHIA G, 1989, LANCET, V2, P797

[23] EPIDEMIOLOGY OF HEPATITIS-C VIRUS - A PRELIMINARY-STUDY IN VOLUNTEER BLOOD-DONORS [J].

STEVENS, CE ;

TAYLOR, PE ;

PINDYCK, J ;

CHOO, QL ;

BRADLEY, DW ;

KUO, G ;

HOUGHTON, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (01) :49-53

[24] CONFIRMATION OF HEPATITIS-C VIRUS-INFECTION BY NEW 4-ANTIGEN RECOMBINANT IMMUNOBLOT ASSAY [J].

VANDERPOEL, CL ;

CUYPERS, HTM ;

REESINK, HW ;

WEINER, AJ ;

QUAN, S ;

DINELLO, R ;

VANBOVEN, JJP ;

WINKEL, I ;

MULDERFOLKERTS, D ;

EXELOEHLERS, PJ ;

SCHAASBERG, W ;

LEENTVAARKUYPERS, A ;

POLITO, A ;

HOUGHTON, M ;

LELIE, PN .

LANCET, 1991, 337 (8737) :317-319

[25] HEPATITIS-C IN CHRONIC LIVER-DISEASE - AN EPIDEMIOLOGIC-STUDY BASED ON 566 CONSECUTIVE PATIENTS UNDERGOING LIVER-BIOPSY DURING A 10-YEAR PERIOD [J].

VERBAAN, H ;

WIDELL, A ;

LINDGREN, S ;

LINDMARK, B ;

NORDENFELT, E ;

ERIKSSON, S .

JOURNAL OF INTERNAL MEDICINE, 1992, 232 (01) :33-42

[26] PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA [J].

WATANABE, J ;

MINEGISHI, K ;

MITSUMORI, T ;

ISHIFUJI, M ;

OGUCHI, T ;

UEDA, M ;

TOKUNAGA, E ;

TANAKA, E ;

KIYOSAWA, K ;

FURUTA, S ;

KATAYAMA, T ;

KUO, G ;

CHOO, QL ;

HOUGHTON, M ;

NISHIOKA, K .

VOX SANGUINIS, 1990, 59 (02) :86-88

[27] DETECTION OF HEPATITIS-C VIRAL SEQUENCES IN NON-A-HEPATITIS NON-B-HEPATITIS [J].

WEINER, AJ ;

KUO, G ;

BRADLEY, DW ;

BONINO, F ;

SARACCO, G ;

LEE, C ;

ROSENBLATT, J ;

CHOO, QL ;

HOUGHTON, M .

LANCET, 1990, 335 (8680) :1-3

[28] MOTHER TO INFANT TRANSMISSION OF HEPATITIS-C VIRUS-INFECTION [J].

WEJSTAL, R ;

HERMODSSON, S ;

IWARSON, S ;

NORKRANS, G .

JOURNAL OF MEDICAL VIROLOGY, 1990, 30 (03) :178-180

[29] THE POLYMERASE CHAIN-REACTION - CLINICAL-APPLICATIONS [J].

WHITE, TJ ;

MADEJ, R ;

PERSING, DH .

ADVANCES IN CLINICAL CHEMISTRY, 1992, 29 :161-196

← 1 2 3 →